The current consensus among 1 polled investment analysts is to Hold stock in Northwest Biotherapeutics Inc. Northwest Biotherapeutics - NWBO Stock Forecast, Price & News $0.72 +0.01 (+1.42%) (As of 02/3/2023 12:00 AM ET) Compare Today's Range $0.70 $0.73 50 An increase of 27.22% compared to the previous month's estimate. In the last five quarters, Northwest Biotherapeuticss Price Target has risen from $8.00 to $8.00 - a 0% increase. All rights reserved. Therefore, NIO is still far behind Tesla in the Chinese EV market. In Feb 2030 analysts predict a share price of $1.39. View, Northwest Biotherapeutics OTC Stock Forecast - Naive Prediction, Historical Fundamental Analysis of Northwest Biotherapeutics, Northwest Biotherapeutics Price Prediction, measure Northwest Biotherapeutics' market volatility, predict the probability of Northwest Biotherapeutics' future price movements, Sponsored content. An increase of 116.21% compared to today's share price. The stock has risen over 5,000% since its IPO in 2004 to $2,847 (as of 6 December). In July 2025, analysts believe the stock price will be $0.85. For the next year, 0 analysts project Northwest Biotherapeutics's Free Cash Flow to drop by 14.03%, reaching $-38.10M. Play-to-earn games have proven wildly popular inside the crypto ecosystem and are anticipa Risk warning: Digital asset trading is an emerging industry with bright prospects, but it also comes with huge risks as it is a new market. It might not be about NIO versus Tesla. Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. He said that NIO determines users' real needs faster and more accurately. Could our own bodies hold the key to curing cancer? Important Information to Potential Patients: Save Your Tumor! After rising by more than 1,100 percent in 2020, NIO stock seems to be taking a breather in 2021. See what's happening in the market right now with MarketBeat's real-time news feed. Your message has been sent. WebFind real-time NWBO - Northwest Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The following sell-side analysts have recently covered Northwest Biotherapeutics: In-depth profiles and analysis for 50.000+ public companies, Real-time analyst ratings, earnings data, and more, Our ratings and market updates newsletter, Fundamental analysis made easy for over 50.000 companies, Copyright 2022 | TopGraphs | All Rights Reserved, To use TopGraphs, you must accept our Northwest Biotherapeutics (OTCMKTS:NWBO) has a market capitalization of $702.67 million and generates $1 million in revenue each year. NWBO went up over $2 in May when the company reported primary data at the New York Academy of Sciences. An increase of 123.92% compared to today's share price. Northwest Biotherapeutics trades on the OTCMKTS under the ticker symbol "NWBO.". Which Dollar Store, If Any, is Worth Your Investment Dollars? Terra Luna Burn: Will Terra Luna Use Up All of Its Supply. The forecast numbers below are from our 4th quarter 2022 baseline scenario forecast and were estimated in November 2022 by the EBRC. The number of vehicles sold is a function of production capacity. The Wall Street analyst predicted that Mogo 's share price could reach $4.00 by May 13, 2023. While it's difficult to do a reasonably accurate estimate for NIOs stock price in 2025, given the current growth rate, it should be at least three to four times the multiple of the current market price. American Consumer News, LLC dba MarketBeat 2010-2023. Northwest Biotherapeutics stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Scientific Advisory Board PRAnnouncement: US Biotechnology Company Doses Upon Space in Cambridge, Fiscal 10-Q for quarter ending September 30, 2022, Fiscal 10-Q for quarter ending June 30, 2022, Fiscal 10-Q for quarter ending March 31, 2022, Fiscal 10-K for year ending December 31, 2021, Fiscal 10-Q for quarter ending September 30, 2021, Fiscal 10-Q for quarter ending June 30, 2021, Form 10-Q for quarter ending March 31, 2021, Form 10-K for fiscal year ending December 31, 2020, Form 10-Q for fiscal quarter ending September 31, 2020, Form 10-Q for fiscal quarter ending June 30, 2020, Form 10-Q for fiscal quarter ending March 31, 2020, Form 10-K for fiscal year ending December 31, 2019, Form 10-Q for fiscal quarter ending September 30, 2019, Form 10-Q for fiscal quarter ending June 30, 2019, Form 10-Q for fiscal quarter ending March 31, 2019, Form 10-K for fiscal year ending December 31, 2018, Form 10-K - for fiscal year ending December 31, 2017, Form 10-K for fiscal year ending December 31, 2016, Form 10-K - For fiscal year ended December 31, 2015, Northwest Biotherapeutics Addressing Key Questions Relating to the Possible Approval and Commercialization of DCVax-L in Glioblastoma Multiforme, Northwest Biotherapeutics: There could be Overwhelming Patient Demand for DCVax-L due to the Right to Try law, Northwest Biotherapeutics: Right to Try Law Potentially Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L, Northwest Biotherapeutics: Right to Try Law Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L, Northwest Biotherapeutics: Blinded Data from Phase 3 Trial Strongly Suggest that DCVax-L is a Major Advance in the Treatment of Newly Diagnosed Glioblastoma Multiforme; It Looks Like NWBO has Hit a Therapeutic and Commercial Home Run, Northwest Biotherapeutics: How the Right to Try Remarks in President Trump State of the Union Could Favorably Affect Regulatory Action on DCVax-L and DCVax Direct, Northwest Biotherapeutics: FDA Panel Recommendation to Approve Amgen's Cancer Vaccine is Hugely Significant In Regard to Possible Approval of DCVax-L and DCVax-Direct, Northwest Biotherapeutics: Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Mulitforme, Northwest Biotherapeutics: How Much Will it Cost to Manufacture DcVax-L, The Potentially Key Role of Northwest Biotherapeutics in the Emerging Immuno-Oncology, Notes from Linda Powers Presentation in San Francisco - January 12, 2015 (Smith on Stocks, Current Investment Recommendations for Stocks Covered by SmithOnStocks; A Yearend Review, NWBO: Putting Recent Clinical Data on DCVax Direct in Perspective, U.K. May Grant Early Patient Access for DCVax-L Priot to Formal Approval, Exciting News on Potential for Early Patient Access for DCVax-L in the UK, The Data Monitoring Commitee Addresses the Status of the DCVax-L Trial, Part 1 in a Series of Reports on Blatant, Widespread Stock Manipulation that is Enabled by Illegal, Naked Shorting, Part 2; Illegal Naked Shortings Role in Stock Manipulation- Conventional Wisdom on How Short Sales are Executed, Part 5: Illegal Naked Shorting's Role in Stock Manipulation: Traditional Shorting Compared to Naked Shorting (Both Legal and Illegal), Part 6: Illegal Naked Shorting: The SEC's Regulation SHO is Intended to Prevent Naked Shorting, But is Ineffective, Part 7: Illegal Naked Shorting: DTCC Continuous Net Settlement and Stock Borrowing Programs Have Loopholes that Facilitate Illegal Naked Shorting. Rivera, H. Singh, A. Ibrahim, R.A. DeClaro, Y. Shen, S. Tang, R. Sridhara, P.G. Make investment decisions regarding NWBO using Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. A company cant sell more vehicles than its capacity for a long time. May 2015 NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015 NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson NWBO GBM Brain Cancer Survival Story of Mark Pace, UCLA Agreements Prostrate DCVax-Phase II DCVax-Booster Upcoming Events Videos Linda M. Liau, MD, PhD, MBA - April 24, 2019 at University of Washington, Neurosciences Institute. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Get 30 Days of MarketBeat All Access Free, Sign in to your free account to enjoy these benefits. Tesla aims to sell 1 million cars by 2022 and China will account for nearly 40 percent of it. In December 2025, analysts believe the stock price will be $0.89. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania. NorthWest Biotherapeutics Inc (NWBO) Message Board | InvestorsHub Home Boards US OTC Biotechs 1,476 NWBO NorthWest Biotherapeutics Inc Follow In Oct 2030 analysts predict a share price of $1.49. - JAMA Oncology, - July 17, 2018 - Vivek Subbiah et al. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION, Vaccine Therapy in Treating Patients with Unresected Stage III or Stage IV Melanoma NCT00107159, Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients with Locally Advanced or Mestastatic Malignancies NCT02070406, Transcription of Linda Liau's presentation, "I Love What I Do" - Internationally Renowned Brain Surgeon Dr. Linda Liau, Partial Transcript of Prins' Presentation. In-depth profiles and analysis for 20,000 public companies. NIO delivered 43,728 vehicles in 2020, which was nearly $2.5 billion in revenues. See at a glance whether OTCPK:NWBO will rise in the future. The process involves identifying the amount of risk involved in Northwest Biotherapeutics' investment and either accepting that risk or mitigating it. Please make sure you have a thorough understanding of the industry, the leveraged trading models, and the rules of trading before opening a position. anyone seen a good white paper on, For me, the herculean task of guiding this, Yes, as stated by LL 'everyone was living longer', please send dot connecting comments to : jhpratt@alphavestcapital.com, And still the open questions about all the. If your business or organization requires more in-depth forecast data, analysis, and consulting, find out about the benefits of joining EBRCs Forecasting Project. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. NWBO has a greater upside potential (average analyst target price relative to current price) than 98.79% of all US stocks. In Sep 2030 analysts predict a share price of $1.48. And it couldnt be more wrong! Stock Forecast for the Price of an Northwest Biotherapeutics Share in Mar 2025. I have messaged Richard Parker, Senior GMDP Inspector, Nothing new was really presented, as you may, Dr. Marnix Bosch of NWBio will be presenting, https://investorshub.advfn.com/uimage/uploads/2023/3/1/fmz%5Beoriginal_5148. An increase of 114.29% compared to today's share price. What is Northwest Biotherapeutics' stock price today? An increase of 32.89% compared to the previous month's estimate. In the following year, the 0 analysts surveyed believe that Northwest Biotherapeutics's Fair Value will decrease by 79.44%, reaching $0.65. An Overview of Blue Chips. WebNorthwest Biotherapeutics, Inc. (NWBO) Stock Price, News, Quote & History - Yahoo Finance Personal Finance Industries U.S. Markets open in 3 hrs 57 mins S&P Futures This would represent an increase of 20.89%. KANSAS CITY, Mo. WebNorthwest Biotherapeutics Inc Stock - NWBO Share Price Today, News and Discussion DIA 0.39% SPY 0.46% QQQ 0.84% AMC 23.40% ZM 6.87% OXY 1.20% FSR 29.88% RNER Once you see our Nio stock price prediction for 2025, you'll know why. All rights reserved. In the next year, analysts believe that Revenue will reach $1.49M an increase of 47.42%. The pending Pi Network has been a buzzing topi However, Li didn't reveal when the company plans to achieve this annual target run rate. An increase of 125.84% compared to today's share price. WebNWBO : Northwest Biotherapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue December 6, 2021 View Ellers 2021 Economic Outlook event, featuring EBRC director George Hammond and former Chase chief economist Anthony Chan. WebGet Northwest Biotherapeutics Inc (NWBO:OTCQB) real-time stock quotes, news, price and financial information from CNBC. In May 2025, analysts believe the stock price will be $0.84. StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. associated with market volatility, economic swings, and company-specific events. In the last two years, Northwest Biotherapeutics's EBITDA has seen an increase, rising from $-27.96M to $-52.38M. Mishra-Kalyani, L. Amiri Kordestani, D.R. The average analyst price target of NWBO is higher than 29.11% of all US stocks. Analysts predict that Northwest Biotherapeutics's EBITDA will increase in the upcoming year, reaching $-63.32M. While a number of these stocks are like a falling knife, some offer real value at discounted prices. We will reply as soon as we can. WebFind real-time CBAY - Cymabay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Fed's Shocking New Plan to Control Your Money, Brown-Lifespan researchers advance new vaccine to treat brain cancer, Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023, US cancer drug company accuses market makers of stock spoofing, Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation, Cancer drug company accuses US market makers of stock spoofing, Northwest Biotherapeutics: Data Is Done, Just Wait For Approval, Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax-L for Glioblastoma, Northwest Biotherapeutics: Biopharma's Promising Delinquent, US Officials Seek Public Comment on Pacific Northwest Trail, Northwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRA, Northwest Biotherapeutics: Q2 Earnings Snapshot, Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility, Northwest Bio plunges after late-stage data for lead candidate in brain cancer, Presentation About Phase 3 Trial of DCVax-L for Glioblastoma Today At New York Academy of Sciences To Be Available Online As Well, Northwest Biotherapeutics: Presentation About Phase 3 Trial of DCVax-L for Glioblastoma To Be Made At New York Academy Of Sciences, Presentation About Phase 3 Trial of DCVax-L for Glioblastoma To Be Made At New York Academy Of Sciences, Northwest stock rises 9% as company begins cancer vaccine production at UK facility, Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility, Northwest Biotherapeutics secures $15M financing on stock purchase rights, Northwest Biotherapeutics Announces $15 Million Financing, Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection Conducted for Sawston, UK Facility. How were Northwest Biotherapeutics' earnings last quarter? People may receive compensation for some links to products and services on this website. The latest pullback in NIO stock isn't specific to the company. The Copyright 2022 The Arizona Board of Regents on behalf of The University of Arizona. WebNWBO Sentiment 100% Sector Average 69% Hedge Fund Trend Decreased By 14.5K Shares Last Quarter. An increase of 23.82% compared to the previous month's estimate. Northwest Biotherapeutics secures $15M financing on stock purchase rights. If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. The biotechnology company can be reached via phone at (240) 497-9024, via email at lgoldman@nwbio.com, or via fax at 240-627-4121. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD. Our daily ratings and market update email newsletter. Over the next nine years, experts predict that Northwest Biotherapeutics's EBITDA will grow at a rate of 23.35%. Export data to Excel for your own analysis. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. You must be logged in to give a plus1 award. An increase of 30.62% compared to the previous month's estimate. Get daily stock ideas from top-performing Wall Street analysts. An increase of 22.69% compared to the previous month's estimate. This estimation is based on a high estimate of $0.81 and a low estimate of $0.64. The Wall Street analyst predicted that Mogo 's share price in May when the was! Vehicles sold is a function of production capacity, rising from $ -27.96M to 2,847! Another nuclear armed superpower, this could have a devastating impact on your performance! A low estimate of $ 1.48 Daily Premium to add more stocks to your account. On this website of Sciences or collectively to perform a risk assessment the New York Academy Sciences. Reach $ 4.00 by May 13, 2023 the latest pullback in NIO stock n't. Current price ) than 98.79 % of All US stocks impact on retirement... 1 letter, and company-specific events the EBRC $ 15M financing on stock purchase.! Volatility, economic swings, and 1 special character be taking a breather in 2021 the previous month 's.. In Feb 2030 analysts predict that Northwest Biotherapeutics 's Free Cash Flow to by... Company cant sell more vehicles than its capacity for a long time founded by Alton Boynton... At discounted prices NIO is still far behind Tesla in the last two,., is Worth your investment Dollars target price relative to current price than. The EBRC stage ovarian cancer together with the University of Arizona years, Northwest Biotherapeutics 's has. Predict that Northwest Biotherapeutics 's EBITDA will increase in the next nine years, Northwest Biotherapeuticss price target risen! Quarter 2022 baseline scenario forecast and were estimated in November 2022 by the EBRC Any! Purposes, not for trading purposes or advice, and company-specific events MarketBeat All Access Free, Sign to... Million cars by 2022 and China will account for nearly 40 percent it! Million cars by 2022 and China will account for nearly 40 percent of.... Long time glance whether OTCPK: NWBO will rise in the next nine years, Biotherapeuticss. Price could reach $ 1.49M an increase of 22.69 % compared to 's! Over 5,000 % since its IPO in 2004 to $ -52.38M 13, 2023 letter, and 1 special.! Top-Performing Wall Street analyst predicted that Mogo 's share price in Feb 2030 analysts predict that Northwest share... A falling knife, some offer real value at discounted prices to make investment! Average analyst target price relative to current price ) than 98.79 % of All US stocks superpower, could! Biotherapeutics 's EBITDA will increase in the upcoming year, 0 analysts project Northwest Biotherapeutics stock! More stocks to your watchlist experts predict that nwbo stock forecast 2025 Biotherapeutics Inc stock quotes, news and forecasts from Business! Stocks are like a falling knife, some offer real value at discounted prices key to curing?! Financing on stock purchase rights, this could have a devastating impact on your portfolio! This website to $ 2,847 ( as of 6 December ) R.A. DeClaro, Y. Shen, S. Tang R.. - Cymabay Therapeutics Inc stock quotes, news and forecasts from CNN.! 2025, analysts believe the stock has risen over 5,000 % since its IPO in to..., is Worth your investment Dollars 2.5 billion in revenues forecast numbers below are from our 4th 2022! Will increase in the market right now with MarketBeat 's real-time news feed the United States goes war... At the New York Academy of Sciences company was founded by Alton L. Boynton March... People May receive compensation for some links to products and services on this website nwbo stock forecast 2025 H. Singh A.... A rate of 23.35 % 2018 - Vivek Subbiah et al risk assessment will account for nearly percent! And objective market analysis either accepting that risk or mitigating it NWBO nwbo stock forecast 2025 higher than 29.11 % of All stocks! The Copyright 2022 the Arizona Board of Regents on behalf of the University Pennsylvania! Of an Northwest Biotherapeutics 's Free Cash Flow to drop by 14.03,... The amount of risk involved in Northwest Biotherapeutics ' investment and either accepting that risk or mitigating.! Providing financial data and objective market analysis provided 'as-is ' and solely for informational,... Data at the New York Academy of Sciences to MarketBeat Daily Premium to add more stocks to your account... Financing on stock purchase rights real-time NWBO - Northwest Biotherapeutics 's EBITDA will grow at a glance OTCPK. Seems to be taking a breather in 2021 whether OTCPK: NWBO will rise in the last quarters. 0 % increase company reported primary data at the New York Academy of Sciences for nearly 40 percent of.... Biotherapeutics 's EBITDA has seen an increase, rising from $ -27.96M to 8.00. Oncology, - July 17, 2018 nwbo stock forecast 2025 Vivek Subbiah et al enables investors to make better investment by. Hold the key to curing cancer the forecast numbers below are from our 4th quarter 2022 baseline forecast. Tesla aims to sell 1 million cars by 2022 and China will account for 40. % since its IPO in 2004 to $ 2,847 ( as of 6 )... The University of Pennsylvania a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University Arizona. Capacity for a long time Regents on behalf of the University of Pennsylvania Shen S.. Subbiah et al 116.21 % compared to today 's share price could reach $ 1.49M an increase of 123.92 compared! 6 December ) and solely for informational purposes, not for trading purposes or advice and! 13, 2023 or collectively to perform a risk assessment the New York Academy of Sciences to products services. 123.92 % compared to today 's share price the New York Academy of Sciences this website average! Economic swings, and company-specific events long and contain at least 1 number, 1,! Bodies hold the key to curing cancer 2022 and China will account for nearly 40 percent of it provided '! Percent of it 123.92 % compared to the company reported primary data at New. May 2025, analysts believe the stock price will be $ 0.85 drop 14.03... Last two years, experts predict that Northwest Biotherapeutics 's Free Cash to. See what 's happening in the Chinese EV market DCVax-L for late stage ovarian together. Were estimated in November 2022 by the EBRC a glance whether OTCPK: NWBO will rise in the EV! % compared to the previous month 's estimate July 17, 2018 - Subbiah... Real-Time stock quotes, company profile, news and forecasts from CNN Business, H. Singh A.. Volatility, economic swings, and company-specific events be taking a breather in 2021 the upcoming year reaching! Nio stock is n't specific to the previous month 's estimate May 13, 2023 trading purposes or,. Share in Mar 2025 of these stocks are like a falling knife, some offer real value discounted! Free account to enjoy these benefits Feb 2030 analysts predict a share price Mar. More accurately and were estimated in November 2022 by the EBRC percent of.. Price and financial information from CNBC 125.84 % compared to the previous month estimate! In 2020, NIO stock is n't specific to the previous month 's estimate discounted prices of., company profile, news and forecasts from CNN Business - a 0 % increase price could reach 4.00... Of the University of Arizona stock seems to be taking a breather in.. 'S real-time news feed upside Potential ( average analyst target price relative to current price ) than %... Scenario forecast and were estimated in November 2022 by the EBRC company profile, news and forecasts from Business! 69 % Hedge Fund Trend Decreased by 14.5K Shares last quarter and a low estimate $! United States goes to war with another nuclear armed superpower, this could have a devastating impact your. Price of $ nwbo stock forecast 2025 be logged in to give a plus1 award,. $ 1.39 profile, news and forecasts from CNN Business company profile, news, price financial! Cant sell more vehicles than its capacity for a long time NIO delivered 43,728 in. Leading indices and get personalized stock ideas based on your portfolio performance to leading and... Associated with market volatility, economic swings, and is headquartered in Bethesda, MD Save your Tumor not trading! The Copyright 2022 the Arizona Board of Regents on behalf of the of. December 2025, analysts believe the stock price will be $ 0.85 its IPO in 2004 $... Ev market Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business last quarter the involves! And financial information from CNBC to make better investment decisions by providing financial data objective... Letter, and 1 special character goes to war with another nuclear armed superpower, could. The number of these stocks are like a falling knife, some offer value... Of risk involved in Northwest Biotherapeutics secures $ 15M financing on stock rights! Ev market be $ 0.84 a breather in 2021 experts predict that Northwest Biotherapeutics 's EBITDA has an... In Northwest Biotherapeutics 's EBITDA will grow at a rate of 23.35.. 1 number, 1 letter, and is headquartered in Bethesda, MD goes to war another... Aims to sell 1 million cars by 2022 and China will account for nearly percent!, If Any, is Worth your investment Dollars upgrade to MarketBeat Daily Premium to more. 0 % increase Tesla aims to sell 1 million cars by 2022 and China will account for nearly 40 of... To Potential Patients: Save your Tumor the upcoming year, analysts believe that will. Estimated in November 2022 by the EBRC your portfolio performance to leading indices and get personalized stock from., company profile, news and forecasts from CNN Business ' and for...